Agios Pharmaceuticals (AGIO) Earnings Date, Estimates & Call Transcripts $34.41 -1.09 (-3.07%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$34.46 +0.05 (+0.13%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Agios Pharmaceuticals Earnings Summary Agios Pharmaceuticals posted Q1 2025 earnings on May 1, 2025, reporting an EPS of -$1.55, which topped the consensus estimate of -$1.80 by $0.25. Quarterly revenue was reported to be $8.73 million, below the consensus estimate of $9.86 million. With a trailing EPS of $11.24 and a P/E Ratio of 3.06, Agios Pharmaceuticals' earnings are expected to grow next year, from ($6.85) to ($5.79) per share. Upcoming Q2 Earnings DateJul. 30Before Market OpensEstimatedConsensus EPS (May. 1) -$1.80 Actual EPS (May. 1) -$1.55 Beat By $0.25 Actual Revenue (May. 1) $8.73MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)SEC FilingAGIO Upcoming EarningsAgios Pharmaceuticals' next earnings date is estimated for Wednesday, July 30, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Agios Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Agios Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAGIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AGIO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Agios Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$1.81-$1.53-$1.71Q2 20253-$1.81-$1.61-$1.73Q3 20253-$1.89-$1.40-$1.72Q4 20253-$2.22-$1.42-$1.90 FY 2025 12 -$7.73 -$5.96 -$7.05 Q1 20261-$1.65-$1.65-$1.65Q2 20261-$1.73-$1.73-$1.73Q3 20261-$1.80-$1.80-$1.80Q4 20261-$1.90-$1.90-$1.90 FY 2026 4 -$7.08 -$7.08 -$7.08 Q1 20271-$1.56-$1.56-$1.56 Agios Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------5/1/2025Q1 2025-$1.80-$1.55+$0.25-$1.55$9.86M$8.73M2/20/2025Q4 2024-$1.69-$1.74 -$0.05-$1.74$9.35M-8/1/2024Q2 2024-$1.60-$1.69 -$0.09-$1.69$9.34M$8.60M5/2/2024Q1 2024-$1.65-$1.45+$0.20-$1.45$8.37M$8.19M2/15/2024Q4 2023-$1.64-$1.72 -$0.08-$1.72$7.80M$7.10M11/2/2023Q3 2023-$1.69-$1.64+$0.05-$1.64$7.73M$7.40M8/3/2023Q2 2023-$1.60-$1.51+$0.09-$1.51$6.46M$6.70M Agios Pharmaceuticals Earnings - Frequently Asked Questions When is Agios Pharmaceuticals' earnings date? Agios Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on AGIO's earnings history. Did Agios Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Agios Pharmaceuticals (NASDAQ:AGIO) reported ($1.55) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.80) by $0.25. Learn more on analysts' earnings estimate vs. AGIO's actual earnings. How can I listen to Agios Pharmaceuticals' earnings conference call? The conference call for Agios Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Agios Pharmaceuticals' conference call transcript? The conference call transcript for Agios Pharmaceuticals' latest earnings report can be read online. Read Transcript How can I view Agios Pharmaceuticals' earnings report? Agios Pharmaceuticals' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Agios Pharmaceuticals generate each year? Agios Pharmaceuticals (NASDAQ:AGIO) has a recorded annual revenue of $36.50 million. How much profit does Agios Pharmaceuticals generate each year? Agios Pharmaceuticals (NASDAQ:AGIO) has a recorded net income of $673.72 million. AGIO has generated $11.24 earnings per share over the last four quarters. What is Agios Pharmaceuticals' price-to-earnings ratio? Agios Pharmaceuticals (NASDAQ:AGIO) has a trailing price-to-earnings ratio of 3.06. What is Agios Pharmaceuticals' EPS forecast for next year? Agios Pharmaceuticals' earnings are expected to grow from ($6.85) per share to ($5.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies BPMC Earnings BBIO Earnings ROIV Earnings VRNA Earnings RVMD Earnings ELAN Earnings LEGN Earnings GRFS Earnings TGTX Earnings NUVL Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Ahead This page (NASDAQ:AGIO) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
